Warnings and Precautions 5.1 Abuse, Misuse, and Addiction VYVANSE has a high potential for abuse and misuse
In the SURMOUNT-1 trial, participants on the highest dose lost an average of 22.4% of their body weight at 72 weeks numbers that approach what bariatric surgery achieves
However, we found that, while access-related issues were a leading cause of early discontinuation, subsequent switches were frequently attributed to lack of efficacy, injection burden or AEs
We need to support providers and families in creating a culture of health, she says
Four peptides, one 5 mL vial, one injection a day instead of four
Careful screening for personal and familial risk factors for thromboembolism is recommended before initiation.[] The drug is contraindicated in the presence of coagulation disorders, pregnancy and lactation to avoid any catastrophe,[] although potentially life threatening side effects namely deep vein thrombosis, pulmonary embolism and myocardial infarction have not been reported at this low dose.[] However, a variable relapse rate ranging from 9 to 27% has been reported after stopping the medication.[] Glutathione Glutathione, a low molecular weight thiol-peptide plays an important role in maintaining the intracellular redox balance, itself being a powerful antioxidant